Innovative Medicines Canada Private Market Policy Summit – Drug Pricing & Reimbursement

As an industry expert, was invited by IMC to join Advisory colleagues to discuss Drug Plan management and the impact to our private payor clients.

Insights

More Related Articles

The here and now of pharmacogenetic testing

2025 Canadian Leadership Council on Drug Plan Partnerships

e2r Blog Post Alerts – Sick Notes